Table 2.

Selected clinical and laboratory parameters at randomization and on follow-upa

ParameterNo. of Cases with
HypertensionEdemaHypoalbuminemiaHypercholesterolemia and/or Statin TherapyOn ACEI and/or ARBQuality-of-Life Visual Analogue Scale
Group 1Group 2Group 1Group 2Group 1Group 2Group 1Group 2Group 1Group 2Group 1Group 2
At baseline75444346464442004.41 ± 1.194.76 ± 1.07
1 yr1363019b3320b3624c005.69 ± 1.326.95 ± 1.4b
2 yr198c2810b2610b3118b176b6.18 ± 1.047.12 ± 1.09b
5 yr2611c247b248b3417b289b6.43 ± 1.127.26 ± 0.82b
10 yr3516b228b1807b3320b3213b6.61 ± 1.087.31 ± 0.76b
  • a ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.

  • b P < 0.01.

  • c P < 0.05.